Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...

When prices fall, caution comes naturally. Investors hesitate, portfolios are reviewed less often, and even optimists become careful. But w...

India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...

Wright PMS's Sonam Srivastava champions a data-driven approach to active investing, analyzing over 300 data points to identify alpha. Her f...

When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...

Corporate travel in India is increasingly shifting towards smaller cities, with nearly 60% of bookings now originating from or heading to t...

India and Uzbekistan are set to significantly boost bilateral trade, aiming to double it within three years. Discussions at the recent Inte...

As the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...

Currently, India’s FTA utilisation rate hovers around 25% compared to 70-80% in developed economies.

As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...

Abakkus Mutual Fund is strategically allocating 30% to smallcaps within its Flexi Cap Fund, identifying mispriced opportunities despite str...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

Maharashtra's Food and Drug Administration has issued a significant directive. Hospitals and medical practitioners must now allow patients ...

With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...

The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...

Corporate India anticipates salary increments between 8.6% and 10.2% this financial year, driven by demand for skilled talent in high-growt...

India is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...